Pursuing the PFAS Problem
Tackling the challenges of “forever chemicals” in the diagnostics industry.
The Diagnostics Pipeline: Diagnostics Make Up One-Third of Total 2023 Recalls
With recent test recalls announced by Universal Medtech and QuidelOrtho, such products now make up one-third of 2023 total recalls listed by the FDA.
Management Expert Report Cites Weaknesses in Agency’s EUA Processes
...